Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 38
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
Manish Dhawan, Ali A. Rabaan, Mahmoud M. Al Fawarah, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 101-101
Open Access | Times Cited: 33
Pattern-recognition receptors (PRRs) in SARS-CoV-2
Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, et al.
Life Sciences (2023) Vol. 329, pp. 121940-121940
Closed Access | Times Cited: 17
Age-related immune response disparities between adults and children with severe COVID-19: a case–control study in China
Hongliang Chen, Yuan Li, Liping Yuan, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei, et al.
Journal of Pharmacology and Pharmacotherapeutics (2025)
Open Access
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Alison Tarke, Parham Ramezani-Rad, Tertuliano Alves Pereira Neto, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101583-101583
Open Access | Times Cited: 4
Immune system-related soluble mediators and COVID-19: basic mechanisms and clinical perspectives
Mohammad Sadegh Soltani‐Zangbar, Forough Parhizkar, Mojtaba Abdollahi, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Defective antifungal immunity in patients with COVID-19
Oliver Morton, James S. Griffiths, Juergen Loeffler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 ‘cytokine storm’
Jessica Gasparello, Giovanni Marzaro, Chiara Papi, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 3
Open Access | Times Cited: 10
Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling
Harikumar Pallathadka, Abdulrahman Qais Khaleel, Ahmed Hussein Zwamel, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3015-3030
Closed Access | Times Cited: 3
mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infection
Ellie Ivanova, Jasmine Shwetar, Joseph C. Devlin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
Ellie Ivanova, Jasmine Shwetar, Joseph C. Devlin, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108572-108572
Open Access | Times Cited: 9
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2—Review of the Evidence
Izabela Bolesławska, Magdalena Kowalówka, Natasza Bolesławska-Król, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1262-1262
Open Access | Times Cited: 8
Immune exhaustion in ME/CFS and long COVID
Natalie Eaton-Fitch, Penny A. Rudd, Teagan Er, et al.
JCI Insight (2024) Vol. 9, Iss. 20
Open Access | Times Cited: 2
Pathological role of inflammation in ocular disease progress and its targeting by mesenchymal stem cells (MSCs) and their exosome; current status and prospect
Alireza Nouralishahi, Navid Fazlinejad, Renzon Daniel Cosme Pecho, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154619-154619
Closed Access | Times Cited: 6
Multisystem inflammatory syndrome in children and Kawasaki disease; comparison of their clinical findings and one-year follow-up—a cross-sectional study
Saghar Mehrban, Fatemeh Tahghighi, Ehsan Aghaei Moghadam, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2023) Vol. 49, Iss. 1
Open Access | Times Cited: 6
Salivary Alterations of Myeloperoxidase in Patients with Systemic Diseases: A Systematic Review
Kacper Nijakowski, Jakub Jankowski, Dawid Gruszczyński, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12078-12078
Open Access | Times Cited: 6
Clinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients
Samar Habib, Eman Hamza, Randa El-Gamal, et al.
Cureus (2023)
Open Access | Times Cited: 6
SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis
Shahrooz Amin Mozaffari, Ali Salehi, Elnaz Mousavi, et al.
Pathology - Research and Practice (2022) Vol. 239, pp. 154131-154131
Open Access | Times Cited: 9
Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review
Annelise Bocquet-Garçon
Cureus (2024)
Open Access | Times Cited: 1
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
Goran Rondović, Dragan Djordjević, Ivo Udovičić, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2620-2620
Open Access | Times Cited: 8
Serological Evaluation of Antibody Titers After Vaccination Against COVID-19 in 18-44-Year-Old Individuals at a Tertiary Care Center
Rachita Nanda, Prishni Gupta, A. Giri, et al.
Cureus (2023)
Open Access | Times Cited: 4
Potential role of IgM-enriched immunoglobulin as adjuvant treatment in severe SARS-CoV-2 infection
Carlo Tascini, Marco Cotrufo, Emanuela Sozio, et al.
Minerva Anestesiologica (2023) Vol. 89, Iss. 10
Closed Access | Times Cited: 4
Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
Letizia Santinelli, Alessandro Lazzaro, Francesca Sciarra, et al.
Pathogens (2023) Vol. 12, Iss. 3, pp. 442-442
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top